NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $820,196 | +7.7% | 8,128 | -1.8% | 0.26% | +0.4% |
| Q1 2023 | $761,576 | +0.1% | 8,278 | -1.3% | 0.26% | -4.7% |
| Q4 2022 | $760,506 | +19.4% | 8,383 | 0.0% | 0.28% | +13.1% |
| Q3 2022 | $637,000 | -10.2% | 8,383 | 0.0% | 0.24% | -3.6% |
| Q2 2022 | $709,000 | -7.3% | 8,383 | -3.8% | 0.25% | +12.9% |
| Q1 2022 | $765,000 | -17.6% | 8,713 | -17.9% | 0.22% | +1.4% |
| Q4 2021 | $928,000 | +4.9% | 10,613 | -1.9% | 0.22% | -3.5% |
| Q3 2021 | $885,000 | -11.7% | 10,819 | -1.5% | 0.23% | -10.9% |
| Q2 2021 | $1,002,000 | -6.0% | 10,984 | -11.9% | 0.26% | -12.9% |
| Q1 2021 | $1,066,000 | -19.4% | 12,465 | -11.0% | 0.30% | -19.8% |
| Q4 2020 | $1,322,000 | +7.8% | 14,000 | -0.7% | 0.37% | -3.9% |
| Q3 2020 | $1,226,000 | -5.0% | 14,100 | -4.5% | 0.38% | -10.9% |
| Q2 2020 | $1,290,000 | +5.6% | 14,765 | -0.4% | 0.43% | -18.4% |
| Q1 2020 | $1,222,000 | -11.6% | 14,825 | +1.5% | 0.53% | +11.9% |
| Q4 2019 | $1,383,000 | +4.6% | 14,610 | -3.9% | 0.47% | +2.8% |
| Q3 2019 | $1,322,000 | -8.6% | 15,210 | -3.9% | 0.46% | -7.5% |
| Q2 2019 | $1,446,000 | -4.2% | 15,835 | +0.8% | 0.50% | -3.5% |
| Q1 2019 | $1,510,000 | +10.5% | 15,710 | -1.4% | 0.51% | +0.6% |
| Q4 2018 | $1,367,000 | -2.1% | 15,935 | -1.6% | 0.51% | +24.4% |
| Q3 2018 | $1,396,000 | +13.4% | 16,202 | -0.6% | 0.41% | +12.6% |
| Q2 2018 | $1,231,000 | -11.2% | 16,302 | -5.0% | 0.36% | -10.3% |
| Q1 2018 | $1,387,000 | -19.5% | 17,152 | -16.5% | 0.41% | +9.4% |
| Q4 2017 | $1,724,000 | -5.6% | 20,534 | -3.5% | 0.37% | -5.6% |
| Q3 2017 | $1,826,000 | +2.3% | 21,274 | -0.5% | 0.39% | +7.4% |
| Q2 2017 | $1,785,000 | +9.1% | 21,384 | -2.9% | 0.37% | +17.3% |
| Q1 2017 | $1,636,000 | -8.6% | 22,034 | -10.4% | 0.31% | -9.0% |
| Q4 2016 | $1,790,000 | -8.8% | 24,579 | -1.1% | 0.34% | -12.3% |
| Q3 2016 | $1,962,000 | -1.8% | 24,854 | +2.7% | 0.39% | -1.5% |
| Q2 2016 | $1,997,000 | +8.8% | 24,209 | -4.5% | 0.40% | +6.4% |
| Q1 2016 | $1,836,000 | -14.9% | 25,347 | +1.1% | 0.37% | -14.1% |
| Q4 2015 | $2,158,000 | -3.0% | 25,079 | +3.6% | 0.43% | -7.3% |
| Q3 2015 | $2,225,000 | -5.9% | 24,201 | +0.7% | 0.47% | +5.4% |
| Q2 2015 | $2,364,000 | +6.8% | 24,041 | +7.1% | 0.44% | +7.2% |
| Q1 2015 | $2,214,000 | +6.0% | 22,457 | -0.3% | 0.41% | +7.8% |
| Q4 2014 | $2,088,000 | -4.7% | 22,532 | -3.2% | 0.38% | -3.0% |
| Q3 2014 | $2,192,000 | +3.8% | 23,282 | -0.2% | 0.40% | +8.8% |
| Q2 2014 | $2,112,000 | +2.0% | 23,332 | -4.2% | 0.36% | -2.9% |
| Q1 2014 | $2,071,000 | +1.0% | 24,359 | -4.6% | 0.38% | +5.0% |
| Q4 2013 | $2,051,000 | +5.2% | 25,521 | +0.4% | 0.36% | -1.4% |
| Q3 2013 | $1,950,000 | +5.6% | 25,421 | -2.7% | 0.36% | +5.2% |
| Q2 2013 | $1,847,000 | – | 26,121 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |